ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, offering promising progress across different medical and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, far more reputable different for therapeutic use, specifically